LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

TG Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERTGTX
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / TGTX COVERAGE

What’s moving TG Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
TG Therapeutics, Inc. (TGTX) Q4 2025 Earnings Call Transcript

TG Therapeutics, Inc. (TGTX) Q4 2025 Earnings Call Transcript

Investors are testing whether TG Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
TG Therapeutics, Inc. (TGTX) Q3 2025 Earnings Call Transcript

TG Therapeutics, Inc. (TGTX) Q3 2025 Earnings Call Transcript

Investors are testing whether TG Therapeutics, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest TGTX filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-06 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-05 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-02-27 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-08-03 · Period 2026-08-03SEC ↗8-KMaterial company eventFiled 2026-06-12 · Period 2026-06-11SEC ↗8-KMaterial company eventFiled 2026-06-03 · Period 2026-06-03SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-30 · Period 2026-06-11SEC ↗4Official SEC filingFiled 2026-06-15 · Period 2026-06-11SEC ↗
EARNINGS / QUARTERLY TRACKER

TG Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.